Middle Molecule Find

Rulebook › V-tags › V544

V544 Plan: dose of dialysis

Written V0544 on the CMS-2567 and in QCOR.

Enforces 42 CFR 494.90(a)(1) · Appendix H Rev. 246, page 229 · checked 12 Nov 2026

Cited on this tag? What happens after a citation · One-page sheet for the binder

The regulation

§ 494.90(a) Standard: Development of patient plan of care. …The plan of care must address, but not be limited to, the following: (1) Dose of dialysis.… Achieve and sustain the prescribed dose of dialysis to meet a hemodialysis Kt/V of at least 1.2 and a peritoneal dialysis weekly Kt/V of at least 1.7 or meet an alternative equivalent professionally-accepted clinical practice standard for adequacy of dialysis.

Read 42 CFR 494.90 on the eCFR

CMS's interpretive guidance

Interpretive Guidance § 494.90(a)(1)

Note: this guidance is a continuation of the regulatory requirement at § 494.90(a)(1).

The patient plan of care should use dialysis adequacy goals in accordance with current professionally accepted clinical practice standards/CMS CPMs.

The patients’ dialysis prescriptions (dialyzer, blood flow rate, dialysate flow rate, length of treatment time) and the efficacy of the vascular access affect the dose of dialysis delivered. If alarms stop the dialysis ultrafiltration “clock,” the “remaining treatment time,” or planned treatment time may need to be extended to fulfill the patient’s dialysis prescription.

To meet this requirement, the IDT should review the Kt/V results to determine if the patient’s adequacy values achieve the goal. If not, the IDT should compare treatment orders and dialysis treatment records to ensure the prescribed dose of dialysis is being delivered. If the patient is not receiving adequate treatment, the IDT should develop a plan to address the problem. For example, if a conventional 3 times a week HD patient’s Kt/V is below 1.2 for several consecutive testing periods, a causal analysis should be done and the plan of care revised to address the identified problems.

Patients should have a clear understanding of dialysis adequacy and the consequences of skipping or shortening dialysis treatments. If the patient shortens treatments, misses treatments, or gains excessive fluid between treatments, the prescribed dose of dialysis may not be able to be delivered. If a patient routinely shortens or skips treatments, the plan of care for adequate treatment should investigate the root cause(s) (e.g., fear of intradialytic morbidity, prolonged recovery time, schedule conflicts with life responsibilities, transportation issues) and work with the patient to reduce or correct the cause(s). Ultimately, the patient can choose to continue behaviors that result in lessened treatment results. With documentation of educational efforts, the patient’s choice can serve as an explanation for a plan of care that does not achieve standard treatment results.

The requirements for patient assessment of dialysis dose are outlined at V518.

Verbatim from Appendix H Rev. 246, with CMS's headings, lists and bold. Check page 229 (the full 469-page PDF) before quoting it.

Questions on this site that cite it

Rulebook subjects that cite it